Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity
Kathryn Bowman, Daniel Stein, Sally Shin, et al.
mBio (2022) Vol. 13, Iss. 5
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Hybrid Immunity to SARS-CoV-2 from Infection and Vaccination—Evidence Synthesis and Implications for New COVID-19 Vaccines
Júlia Spinardi, Amit Srivastava
Biomedicines (2023) Vol. 11, Iss. 2, pp. 370-370
Open Access | Times Cited: 35
Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination
Xiaogang Tong, R. P. McNamara, María José Avendaño, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 17
Potential immune evasion of the severe acute respiratory syndrome coronavirus 2 Omicron variants
Luyi Chen, Ying He, Hongye Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Protective non-neutralizing SARS-CoV-2 monoclonal antibodies
Arman Izadi, Pontus Nordenfelt
Trends in Immunology (2024) Vol. 45, Iss. 8, pp. 609-624
Open Access | Times Cited: 8
SARS-CoV-2 Evolution: Implications for Diagnosis, Treatment, Vaccine Effectiveness and Development
Fabrizio Angius, Silvia Puxeddu, S Zaimi, et al.
Vaccines (2024) Vol. 13, Iss. 1, pp. 17-17
Open Access | Times Cited: 4
T and B cell responses in different immunization scenarios for COVID-19: a narrative review
Eva Piano Mortari, Pier Francesco Ferrucci, Irini Zografaki, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Severe Acute Respiratory Syndrome Coronavirus 2 Immunology and Coronavirus Disease 2019 Clinical Outcomes
Aljawharah Alrubayyi, Hsinyen Huang, Gaurav D. Gaiha
Infectious Disease Clinics of North America (2025)
Closed Access
Understanding Fc function for rational vaccine design against pathogens
Kathryn Bowman, Paulina Kapłonek, Ryan P. McNamara
mBio (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations
Ruth A Purcell, Robert M. Theisen, Kelly B. Arnold, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Omicron‐specific mRNA vaccine induced cross‐protective immunity against ancestral SARS‐CoV‐2 infection with low neutralizing antibodies
Kuan‐Yin Shen, Chung‐Hsiang Yang, Chiung‐Tong Chen, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 12
Boosting with adjuvanted SCB-2019 elicits superior Fcγ-receptor engagement driven by IgG3 to SARS-CoV-2 spike
Wonyeong Jung, Dansu Yuan, Benjamin P. Kellman, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
Hybrid Immunity against SARS-CoV-2 Variants: A Narrative Review of the Literature
Panagiota Tsagkli, Maria Geropeppa, Ioanna Papadatou, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 1051-1051
Open Access | Times Cited: 2
Progress in vaccine development for infectious diseases—a Keystone Symposia report
Jennifer Cable, Barney S. Graham, Richard A. Koup, et al.
Annals of the New York Academy of Sciences (2023) Vol. 1524, Iss. 1, pp. 65-86
Closed Access | Times Cited: 6
Immune Response after the Fourth Dose of SARS-CoV-2 mRNA Vaccine Compared to Natural Infection in Three Doses’ Vaccinated Solid Organ Transplant Recipients
Rosalia Busà, Giovanna Russelli, Monica Miele, et al.
Viruses (2022) Vol. 14, Iss. 10, pp. 2299-2299
Open Access | Times Cited: 9
Beta-spike-containing boosters induce robust and functional antibody responses to SARS-CoV-2 in macaques primed with distinct vaccines
Yixiang Deng, Caroline Atyeo, Dansu Yuan, et al.
Cell Reports (2023) Vol. 42, Iss. 11, pp. 113292-113292
Open Access | Times Cited: 5
Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection
Thandeka Moyo-Gwete, Simone I. Richardson, Roanne Keeton, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 11, pp. e1011772-e1011772
Open Access | Times Cited: 4
Navigating the Landscape of B Cell Mediated Immunity and Antibody Monitoring in SARS-CoV-2 Vaccine Efficacy: Tools, Strategies and Clinical Trial Insights
Sophie O’Reilly, Joanne Byrne, Eoin R. Feeney, et al.
Vaccines (2024) Vol. 12, Iss. 10, pp. 1089-1089
Open Access | Times Cited: 1
Fcγ receptor-dependent antibody effector functions are required for vaccine protection against infection by antigenic variants of SARS-CoV-2
Samantha Mackin, Pritesh Desai, Bradley Whitener, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Cross-protection and cross-neutralization capacity of ancestral and VOC-matched SARS-CoV-2 adenoviral vector-based vaccines
Sabrina E. Vinzón, María Verónica Lopez, Eduardo G. Cafferata, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 3
Long-Term Effectiveness of BNT162b2 Pfizer-BioNTech mRNA-Based Vaccine on B Cell Compartment: Efficient Recall of SARS-CoV-2-Specific Memory B Cells
Rosalia Busà, Monica Miele, Maria Concetta Sorrentino, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15046-15046
Open Access | Times Cited: 4
Role of prior immunity in binding to spike of “future” Omicron subvariants
Deepayan Biswas, Gokulnath Mahalingam, Rajesh Kumar Subaschandrabose, et al.
Indian Journal of Medical Microbiology (2024) Vol. 50, pp. 100615-100615
Open Access
Hybrid adaptive immunity to SARS-CoV-2 protects against breakthrough infection after COVID-19 vaccination in ALSPAC participants.
Holly E. Baum, Marianna Santopaolo, Ore Francis, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Effectiveness and duration of additional immune defense provided by SARS-CoV-2 infection before and after receiving the mRNA COVID-19 vaccine BNT162b2
Nagashige Shimada, Satoshi Sugawa, Satoshi Murakami, et al.
Vaccine X (2024) Vol. 19, pp. 100518-100518
Open Access
Neutralizing and binding antibody responses to SARS-CoV-2 with hybrid immunity in pregnancy
Lin Li, Yusuke Matsui, Mary Prahl, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access
SARS-CoV-2 infection prior to vaccination amplifies Fc-mediated humoral profiles in an age-dependent manner
Wonyeong Jung, Arturo Abdelnour, Paulina Kapłonek, et al.
Cell Reports (2024) Vol. 43, Iss. 9, pp. 114684-114684
Open Access
Page 1 - Next Page

Scroll to top